テネシーにおける肺疾患の臨床試験
テネシー内の拠点で、肺疾患に関する15件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- SCRI Oncology Partners, Nashville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06765109A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- WR-Clinsearch, LLC, Chattanooga
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- University of Tennessee Medical Center, Knoxville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- West Tennessee Research Institute, Jackson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Vanderbilt University Medical Center, Nashville
被験者募集中観察研究健康なボランティア歓迎
25歳〜35歳 · 全性別 · 2026/09/23更新 · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Sarah Cannon Research Institue, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Premier Research Center, LLC, Hendersonville
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/22更新 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Tennessee Oncology Chattanooga, Chattanooga
- University of Tennessee Medical Center, Knoxville
- Baptist Memorial Hospital-Memphis, Memphis
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Trials Center of Middle Tennesee LLC, Franklin
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/03更新 · NCT07284602A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- SCRI Oncology Partners, Nashville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/01更新 · NCT05967689Cooperative Assessment of Late Effects for SCD Curative Therapies
- Vanderbilt University Medical Center, Nashville
被験者募集中観察研究
4歳〜65歳 · 全性別 · 2026/07/27更新 · NCT05153967Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Tennessee Medical Center, Knoxville
- Baptist Cancer Center, Memphis
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/06/26更新 · NCT04614103A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/15更新 · NCT06619561ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。